FGF2 and thyroid gland carcinoma: Then, using a number of cell lines from various thyroid cancer subtypes, we checked whether the negative correlation of PROX1 and FGF2 expression is a characteristic feature of FTCs or whether it occurs also in other thyroid cancers, such as PTCs and anaplastic cancer.